Endovascular CSF Shunt Placement for Minimally Invasive Hydrocephalus Drainage
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing treatments for hydrocephalus and intracranial hypertension, such as ventriculoperitoneal shunts, suffer from high failure rates, complications, and invasive procedures, with minimal design improvements in decades.
Innovation Solution
A minimally invasive endovascular approach using a delivery catheter to deploy a CSF shunt through the venous system, accessing the subarachnoid space via venous branches or the third ventricle, allowing CSF drainage into the venous system, utilizing imaging guidance and expandable anchors for secure placement.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If ventriculoperitoneal shunts are used to drain CSF, then CSF drainage is achieved, but the procedure becomes highly invasive with skull drilling and high failure rates
Solution Approach 1:
Instead of accessing the ventricle through skull drilling and routing the shunt externally or to the peritoneum, this invention inverts the approach by accessing the subarachnoid space through the venous system from below. The shunt is delivered endovascularly through veins to reach the lumbar subarachnoid space, eliminating the need for craniotomy and external routing.
Solution Approach 2:
The venous system serves as an intermediary pathway to reach the subarachnoid space. Rather than directly penetrating the skull and dura to access the ventricle, the invention uses the naturally occurring venous channels as a conduit to deliver the shunt to the target location, reducing tissue disruption.
2Object-affected harmful factors
If traditional shunt procedures are performed, then CSF drainage is established, but infection risk and over-drainage complications increase
Solution Approach 1:
The shunt utilizes the body's own venous system as the drainage pathway, allowing CSF to flow naturally into the venous circulation where it is processed and redistributed. This self-service approach eliminates the need for external reservoirs or peritoneal routing, reducing infection risk while maintaining physiological drainage.
Solution Approach 2:
The invention leverages the pressure gradient between the subarachnoid space and venous system to drive CSF flow. By connecting these two fluid systems, the shunt creates a hydraulic pathway that allows natural pressure-driven flow without requiring external pumps or complex regulation mechanisms.
3Object-affected harmful factors
If minimally invasive endovascular approach is used, then surgical trauma is reduced, but precise positioning and secure placement become more challenging
Solution Approach 1:
The shunt incorporates radiopaque markers or contrast elements that allow visualization under fluoroscopy or other imaging modalities. These visual indicators enable precise positioning verification during the endovascular delivery process, ensuring accurate placement despite the minimally invasive approach.
Solution Approach 2:
The shunt device combines multiple materials with different properties, including radiopaque components for imaging visibility, biocompatible materials for tissue compatibility, and potentially shape-memory or expandable elements for secure anchoring. This composite construction enables both precise positioning and stable placement.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Reduces the risk of complications by avoiding skull drilling and provides a more physiological CSF drainage, minimizing over-drainage and infection risks, with a stable and effective CSF flow regulation.
Implementation Method 1
A positive pressure gradient between the CSF pressure of the subarachnoid space and the blood pressure of the venous system may contribute to the natural absorption of CSF through arachnoid granulations
Data Source
AI summary
Methods for deploying and removing an endovascular cerebrospinal fluid (CSF) shunt device in a patient's spinal subarachnoid space or third ventricle are disclosed herein. The disclosed methods can be used to treat elevated CSF pressure (e.g., acquired communicating hydrocephalus, pseudotumor cerebri), normal pressure hydrocephalus, or as a temporary measure to drain CSF and/or blood from the subarachnoid space instead of inserting an external ventricular drain in the patient.


